USP25 promotes pathological HIF-1-driven metabolic reprogramming and is a potential therapeutic target in pancreatic cancer. (2022)
Attributed to:
Stochastic fluctuations during mammary development and breast cancer morphogenesis
funded by
SPF
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1038/s41467-022-29684-9
PubMed Identifier: 35440539
Publication URI: http://europepmc.org/abstract/MED/35440539
Type: Journal Article/Review
Volume: 13
Parent Publication: Nature communications
Issue: 1
ISSN: 2041-1723